LeMaitre Vascular, Inc. (LMAT)
USD 90.34
(-0.65%)
USD 90.34
(-0.65%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 48.99 Million USD | 52.29% |
| 2022 | 36.92 Million USD | -16.45% |
| 2021 | 45.98 Million USD | 29.88% |
| 2020 | 36.89 Million USD | 33.11% |
| 2019 | 27.09 Million USD | 59.74% |
| 2018 | 32.76 Million USD | -37.16% |
| 2017 | 25.16 Million USD | 29.18% |
| 2016 | 19.84 Million USD | 51.36% |
| 2015 | 14.81 Million USD | 37.49% |
| 2014 | 9.65 Million USD | 73.75% |
| 2013 | 7.13 Million USD | 20.67% |
| 2012 | 6.22 Million USD | -48.34% |
| 2011 | 5.78 Million USD | -6.16% |
| 2010 | 5.43 Million USD | 41.42% |
| 2009 | 3.66 Million USD | 482.82% |
| 2008 | -1.16 Million USD | 379.7% |
| 2007 | -1.3 Million USD | -130.99% |
| 2006 | 1.08 Million USD | -67.16% |
| 2005 | 1.96 Million USD | 14.23% |
| 2004 | 2.24 Million USD | -86.05% |
| 2003 | 20.66 Million USD | 2380.67% |
| 2002 | 833 Thousand USD | 395.39% |
| 2001 | -282 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 16.97 Million USD | -7.1% |
| 2024 Q2 | 16.76 Million USD | 17.59% |
| 2024 Q1 | 14.25 Million USD | 3.63% |
| 2023 FY | - USD | 52.29% |
| 2023 Q1 | 8.9 Million USD | 14.25% |
| 2023 Q2 | 9.62 Million USD | 8.06% |
| 2023 Q3 | 9.36 Million USD | -2.68% |
| 2023 Q4 | 12.59 Million USD | 34.45% |
| 2022 FY | - USD | -16.45% |
| 2022 Q2 | 9.05 Million USD | 12.72% |
| 2022 Q1 | 8.03 Million USD | -4.81% |
| 2022 Q4 | 7.79 Million USD | 21.58% |
| 2022 Q3 | 6.41 Million USD | -29.19% |
| 2021 Q2 | 11.1 Million USD | 39.78% |
| 2021 Q3 | 9.12 Million USD | -17.83% |
| 2021 FY | - USD | 29.88% |
| 2021 Q4 | 8.44 Million USD | -7.51% |
| 2021 Q1 | 7.94 Million USD | -16.45% |
| 2020 Q3 | 9.57 Million USD | 96.49% |
| 2020 FY | - USD | 33.11% |
| 2020 Q4 | 9.51 Million USD | -0.66% |
| 2020 Q1 | 4.35 Million USD | -11.67% |
| 2020 Q2 | 4.87 Million USD | 11.92% |
| 2019 Q1 | 4.43 Million USD | 10.96% |
| 2019 Q3 | 5.9 Million USD | -0.17% |
| 2019 Q4 | 4.92 Million USD | -16.55% |
| 2019 FY | - USD | 59.74% |
| 2019 Q2 | 5.91 Million USD | 33.37% |
| 2018 Q3 | 4.61 Million USD | 2286.26% |
| 2018 Q1 | 4.86 Million USD | -23.09% |
| 2018 FY | - USD | -37.16% |
| 2018 Q4 | 3.99 Million USD | -13.35% |
| 2018 Q2 | -211 Thousand USD | -104.34% |
| 2017 FY | - USD | 29.18% |
| 2017 Q4 | 6.32 Million USD | 25.11% |
| 2017 Q3 | 5.05 Million USD | -8.72% |
| 2017 Q2 | 5.53 Million USD | 32.03% |
| 2017 Q1 | 4.19 Million USD | 7.27% |
| 2016 FY | - USD | 51.36% |
| 2016 Q3 | 5.34 Million USD | 41.26% |
| 2016 Q2 | 3.78 Million USD | 14.64% |
| 2016 Q4 | 3.9 Million USD | -26.85% |
| 2016 Q1 | 3.3 Million USD | 6.83% |
| 2015 Q4 | 3.08 Million USD | 18.76% |
| 2015 FY | - USD | 37.49% |
| 2015 Q3 | 2.6 Million USD | -6.91% |
| 2015 Q2 | 2.79 Million USD | 21.0% |
| 2015 Q1 | 2.3 Million USD | -21.11% |
| 2014 Q3 | 1.86 Million USD | -24.68% |
| 2014 Q4 | 2.92 Million USD | 56.69% |
| 2014 FY | - USD | 73.75% |
| 2014 Q1 | 575 Thousand USD | -50.94% |
| 2014 Q2 | 2.48 Million USD | 331.3% |
| 2013 Q3 | 776 Thousand USD | -46.37% |
| 2013 Q4 | 1.17 Million USD | 51.03% |
| 2013 Q1 | 1.07 Million USD | 149.53% |
| 2013 FY | - USD | 20.67% |
| 2013 Q2 | 1.44 Million USD | 34.86% |
| 2012 Q3 | 994 Thousand USD | -33.91% |
| 2012 Q4 | 430 Thousand USD | -56.74% |
| 2012 Q2 | 1.5 Million USD | -6.0% |
| 2012 Q1 | 1.6 Million USD | 5.47% |
| 2012 FY | - USD | -48.34% |
| 2011 FY | - USD | -6.16% |
| 2011 Q1 | 1.52 Million USD | 15.59% |
| 2011 Q2 | 2.19 Million USD | 44.21% |
| 2011 Q3 | 2.17 Million USD | -1.0% |
| 2011 Q4 | 1.51 Million USD | -30.09% |
| 2010 Q3 | 2.35 Million USD | -3.17% |
| 2010 Q4 | 1.31 Million USD | -44.14% |
| 2010 FY | - USD | 41.42% |
| 2010 Q1 | 1.24 Million USD | -22.83% |
| 2010 Q2 | 2.43 Million USD | 95.42% |
| 2009 Q2 | 1.41 Million USD | 135.71% |
| 2009 Q1 | 602 Thousand USD | 1194.55% |
| 2009 FY | - USD | 482.82% |
| 2009 Q4 | 1.61 Million USD | -3.13% |
| 2009 Q3 | 1.66 Million USD | 17.27% |
| 2008 FY | - USD | 379.7% |
| 2008 Q2 | 364 Thousand USD | 159.0% |
| 2008 Q3 | 1.24 Million USD | 241.48% |
| 2008 Q4 | -55 Thousand USD | -104.42% |
| 2008 Q1 | -617 Thousand USD | -2985.0% |
| 2007 FY | - USD | -130.99% |
| 2007 Q4 | -20 Thousand USD | -103.57% |
| 2007 Q2 | -215 Thousand USD | 67.33% |
| 2007 Q3 | 560 Thousand USD | 360.47% |
| 2007 Q1 | -658 Thousand USD | -75.94% |
| 2006 Q1 | 839 Thousand USD | 103.91% |
| 2006 Q4 | -374 Thousand USD | -155.24% |
| 2006 FY | - USD | -67.16% |
| 2006 Q3 | 677 Thousand USD | 1209.84% |
| 2006 Q2 | -61 Thousand USD | -107.27% |
| 2005 Q3 | 7.82 Million USD | 3.85% |
| 2005 Q4 | -21.43 Million USD | -374.05% |
| 2005 Q2 | 7.53 Million USD | 0.39% |
| 2005 FY | - USD | 14.23% |
| 2005 Q1 | 7.5 Million USD | 141.57% |
| 2004 FY | - USD | -86.05% |
| 2004 Q4 | -18.04 Million USD | -375.68% |
| 2004 Q1 | 6.54 Million USD | 0.0% |
| 2004 Q3 | 6.54 Million USD | 0.0% |
| 2004 Q2 | 6.54 Million USD | 0.0% |
| 2003 FY | - USD | 2380.67% |
| 2002 FY | - USD | 395.39% |
| 2001 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 207.359% |
| AngioDynamics, Inc. | -14.29 Million USD | 442.779% |
| AtriCure, Inc. | -8.1 Million USD | 704.144% |
| Avinger, Inc. | -16.34 Million USD | 399.706% |
| Azenta, Inc. | 55.15 Million USD | 11.171% |
| BioLife Solutions, Inc. | -45.23 Million USD | 208.294% |
| The Cooper Companies, Inc. | 882.8 Million USD | 94.451% |
| Daxor Corporation | 329.74 Thousand USD | -14757.16% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 471.193% |
| Femasys Inc. | -13.16 Million USD | 471.998% |
| GlucoTrack, Inc. | -7.09 Million USD | 790.876% |
| Harvard Bioscience, Inc. | 9.49 Million USD | -416.064% |
| Hologic, Inc. | 1.29 Billion USD | 96.22% |
| ICU Medical, Inc. | 307.69 Million USD | 84.078% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 97.954% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 621.193% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 845.08% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 845.08% |
| Masimo Corporation | 236.7 Million USD | 79.303% |
| Microbot Medical Inc. | -10.63 Million USD | 560.692% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | -210.642% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 78.833% |
| Nephros, Inc. | -1.37 Million USD | 3652.574% |
| NovoCure Limited | -175.86 Million USD | 127.857% |
| NEXGEL, Inc. | -2.73 Million USD | 1894.505% |
| NEXGEL, Inc. | -2.73 Million USD | 1894.505% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 156.638% |
| OraSure Technologies, Inc. | 76.15 Million USD | 35.673% |
| Pro-Dex, Inc. | 8.33 Million USD | -487.904% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 215.632% |
| Predictive Oncology Inc. | -13.18 Million USD | 471.643% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 2050.277% |
| QuidelOrtho Corporation | 545.6 Million USD | 91.021% |
| Repligen Corporation | 124.29 Million USD | 60.585% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 17045.869% |
| STAAR Surgical Company | 33.22 Million USD | -47.467% |
| Sharps Technology, Inc. | -8.98 Million USD | 645.522% |
| Utah Medical Products, Inc. | 24.8 Million USD | -97.501% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 78.884% |
| Jin Medical International Ltd. | 3.44 Million USD | -1322.935% |